
Congress Clears Path for ACT for ALS Reauthorization
With the September 30 deadline looming, Congress has passed the Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026. The bipartisan bill now moves to the President’s desk, ensuring that vital research infrastructure and expanded access to investigational therapies for the neurodegenerative disease continue through 2031.
























